In Silico Prediction and In Vitro Assessment Service
MedPharm’s in silico models are based on 20 years of experience. Each model ranks the ability of compounds to penetrate tissue based on key physiochemical information. Combining in silico investigations with API characterization helps our clients to make informed decisions on compound selection early in the development pathway. Our in vitro assessments allow compounds to be selected based on activity and permeability in ex vivo human tissue.
-
Most popular related searches
Customer reviews
No reviews were found for In Silico Prediction and In Vitro Assessment Service. Be the first to review!